Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 526b (miR-526b) is a small non-coding RNA molecule encoded in the chromosome 19 microRNA cluster (C19MC), the largest primate-specific miRNA cluster[1][2][3]. miR-526b is transcribed as part of a primary miRNA transcript, processed to a mature form that becomes incorporated into the RNA-induced silencing complex (RISC), where it mediates post-transcriptional suppression of gene expression by binding to complementary sequences in target mRNAs, typically leading to translation inhibition or degradation[3]. miR-526b has been shown to target genes such as MMP1 and Ku80, impacting processes like extracellular matrix remodeling, apoptosis, cell proliferation, and cancer pathways[1][3]. Upregulation and downregulation of miR-526b have been associated with various cancers, and it is mainly studied as a regulator or putative biomarker rather than a classical drug target[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 526b (miR-526b).